We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biohazard Spore Monitor Detects Clostridium Difficile Superbug

By HospiMedica International staff writers
Posted on 04 May 2009
An airborne bacterial spore monitor is capable of detecting the hypervirulent bacteria Clostridium difficile, responsible for 15,000 to 20,000 fatalities annually.

The BSM-2000 System continuously samples air at a rate of 100 liters per minute, and uses heat to "pop” the airborne bacterial spores, releasing a chemical called dipicolinic acid which is unique to bacterial spores. More...
The released acid reacts with a sensor--composed of amacrocyclic ligand bonded to terbium--triggering luminescence under ultraviolet (UV light). The degree of luminescence is directly correlated to the number of spores captured, thus giving a positive result if the captured spore count surpasses the threshold set on the device. The system is designed for constant and unattended monitoring of public spaces. The BSM-2000 System is a product of Universal Detection Technology (UNDT, Los Angeles, CA, USA), and is based on technology licensed from the U.S. National Aeronautics and Space Administration (NASA, Washington, DC, USA).

"The BSM-2000's detection method for detecting anthrax can also be used for detecting C. difficile, which is also a spore forming bacteria,” said Amir Ettehadieh, B.A., director of research and development at UNDT. "The BSM-2000 can effectively and cheaply monitor an environment such has a hospital or nursing home for the presence of this superbug.”

C. difficile is a species of Gram-positive bacteria of the genus Clostridium, an anaerobic, spore-forming family of rods (bacillus). C. difficile is the most serious cause of antibiotic-associated diarrhea (AAD) and can lead to pseudomembranous colitis, often resulting from eradication of the normal gut flora by antibiotics. When this happens, C. difficile bacteria, which naturally reside in the body, become overgrown, releasing toxins that can cause bloating, constipation, and diarrhea with abdominal pain, which may become severe. Latent symptoms often mimic some flu-like symptoms. Discontinuation of causative antibiotic treatment is often curative; in more serious cases, oral administration of metronidazole or vancomycin is the treatment of choice.

Related Links:
Universal Detection Technology
U.S. National Aeronautics and Space Administration



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.